Neutrophil-to-lymphocyte ratio after pazopanib treatment predicts response in patients with advanced soft-tissue sarcoma

被引：0
|
作者：
Hiroshi Kobayashi
Tomotake Okuma
Hiroyuki Oka
Toshihide Hirai
Takahiro Ohki
Masachika Ikegami
Ryoko Sawada
Yusuke Shinoda
Toru Akiyama
Kenji Sato
Satoshi Abe
Hirotaka Kawano
Takahiro Goto
Sakae Tanaka
机构：
[1] The University of Tokyo Hospital,Department of Orthopaedic Surgery, Faculty of Medicine
[2] Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital,Department of Musculoskeletal Oncology
[3] The University of Tokyo Hospital,Department of Medical Research and Management for Musculoskeletal Pain, 22nd Century Medical and Research Center, Faculty of Medicine
[4] Jichi Medical University,Department of Orthopaedic Surgery, Saitama Medical Center
[5] University of Teikyo,Department of Orthopaedic Surgery, Faculty of Medicine
来源：
International Journal of Clinical Oncology | 2018年 / 23卷
关键词：
Soft-tissue sarcoma; Pazopanib; Chemotherapy; Neutrophil-to-lymphocyte ratio;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：368 / 374
页数：6
相关论文
共 50 条
  • [1] Neutrophil-to-lymphocyte ratio after pazopanib treatment predicts response in patients with advanced soft-tissue sarcoma
    Kobayashi, Hiroshi
    Okuma, Tomotake
    Oka, Hiroyuki
    Hirai, Toshihide
    Ohki, Takahiro
    Ikegami, Masachika
    Sawada, Ryoko
    Shinoda, Yusuke
    Akiyama, Toru
    Sato, Kenji
    Abe, Satoshi
    Kawano, Hirotaka
    Goto, Takahiro
    Tanaka, Sakae
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (02) : 368 - 374
  • [2] Pre-Treatment Neutrophil-to-Lymphocyte Ratio (NLR) as a Predictive Marker of Pazopanib Treatment for Soft-Tissue Sarcoma
    Sato, Yasuyoshi
    Nakano, Kenji
    Wang, Xiaofei
    Fukuda, Naoki
    Urasaki, Tetsuya
    Ohmoto, Akihiro
    Hayashi, Naomi
    Yunokawa, Mayu
    Ono, Makiko
    Tomomatsu, Junichi
    Saito, Masanori
    Minami, Yusuke
    Hayakawa, Keiko
    Funauchi, Yuki
    Tanizawa, Taisuke
    Ae, Keisuke
    Matsumoto, Seiichi
    Takahashi, Shunji
    CANCERS, 2021, 13 (24)
  • [3] Pre-treatment Neutrophil-to-Lymphocyte Ratio Predicts Efficacy of Eribulin for Soft-tissue Sarcoma
    Sato, Yasuyoshi
    Nakano, Kenji
    Fukuda, Naoki
    Wang, Xiaofei
    Urasaki, Tetsuya
    Ohmoto, Akihiro
    Yunokawa, Mayu
    Ono, Makiko
    Tomomatsu, Junichi
    Hayakawa, Keiko
    Funauchi, Yuki
    Tanizawa, Taisuke
    Ae, Keisuke
    Matsumoto, Seiichi
    Takahashi, Shunji
    ANTICANCER RESEARCH, 2021, 41 (01) : 527 - 532
  • [4] Pazopanib for the treatment of soft-tissue sarcoma
    Heudel, Pierre
    Cassier, Philippe
    Derbel, Olfa
    Dufresne, Armelle
    Meeus, Pierre
    Thiesse, Philippe
    Ranchere-Vince, Dominique
    Blay, Jean Yves
    Ray-Coquard, Isabelle
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2012, 4 : 65 - 70
  • [5] Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in patients with soft tissue sarcoma A meta-analysis
    Liu, Gang
    Ke, Li-chi
    Sun, Sheng-rong
    MEDICINE, 2018, 97 (36)
  • [6] Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients
    Szkandera, J.
    Absenger, G.
    Liegl-Atzwanger, B.
    Pichler, M.
    Stotz, M.
    Samonigg, H.
    Glehr, M.
    Zacherl, M.
    Stojakovic, T.
    Gerger, A.
    Leithner, A.
    BRITISH JOURNAL OF CANCER, 2013, 108 (08) : 1677 - 1683
  • [7] Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients
    J Szkandera
    G Absenger
    B Liegl-Atzwanger
    M Pichler
    M Stotz
    H Samonigg
    M Glehr
    M Zacherl
    T Stojakovic
    A Gerger
    A Leithner
    British Journal of Cancer, 2013, 108 : 1677 - 1683
  • [8] The derived neutrophil/lymphocyte ratio predicts poor clinical outcome in soft tissue sarcoma patients
    Szkandera, Joanna
    Gerger, Armin
    Liegl-Atzwanger, Bernadette
    Stotz, Michael
    Samonigg, Hellmut
    Friesenbichler, Joerg
    Stojakovic, Tatjana
    Leithner, Andreas
    Pichler, Martin
    AMERICAN JOURNAL OF SURGERY, 2015, 210 (01) : 111 - 116
  • [9] Cost-effectiveness of pazopanib in advanced soft-tissue sarcoma in Canada
    Delea, T. E.
    Amdahl, J.
    Nakhaipour, H. R.
    Manson, S. C.
    Wang, A.
    Fedor, N.
    Chit, A.
    CURRENT ONCOLOGY, 2014, 21 (06) : E748 - E759
  • [10] Neutrophil-to-lymphocyte ratio predicts delirium after stroke
    Guldolf, Kaat
    Vandervorst, Fenne
    Gens, Robin
    Ourtani, Anissa
    Scheinok, Thomas
    De Raedt, Sylvie
    AGE AND AGEING, 2021, 50 (05) : 1626 - 1632
12345